Stuart Keller

548 total citations
15 papers, 205 citations indexed

About

Stuart Keller is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Rheumatology. According to data from OpenAlex, Stuart Keller has authored 15 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Hematology and 5 papers in Rheumatology. Recurrent topics in Stuart Keller's work include Autoimmune and Inflammatory Disorders Research (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Stuart Keller is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Stuart Keller collaborates with scholars based in United States, United Kingdom and France. Stuart Keller's co-authors include Paul Schweitzer, Pierre Quartier, Ran Liao, Catherine Guly, Stephanie de Bono, Douglas Schlichting, Mark B. Effron, Athimalaipet V Ramanan, Kim Papp and Renata Gontijo Lima and has published in prestigious journals such as Journal of the American College of Cardiology, Annals of the Rheumatic Diseases and British Journal of Dermatology.

In The Last Decade

Stuart Keller

12 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Keller United States 6 93 64 55 40 38 15 205
Jacek Musiał Poland 6 64 0.7× 15 0.2× 19 0.3× 9 0.2× 23 0.6× 21 183
Kathrin Danninger Austria 8 99 1.1× 46 0.7× 12 0.2× 2 0.1× 53 1.4× 12 194
Karolis Ažukaitis Lithuania 8 47 0.5× 20 0.3× 11 0.2× 1 0.0× 26 0.7× 24 130
Bassam Mahboub United Arab Emirates 7 24 0.3× 23 0.4× 3 0.1× 22 0.6× 25 0.7× 13 179
Nicole Michon Canada 5 78 0.8× 33 0.5× 98 1.8× 31 0.8× 7 280
Hannah Fleming Ireland 9 5 0.1× 36 0.6× 9 0.2× 39 1.0× 16 0.4× 11 175
François-Xavier Lapébie France 7 27 0.3× 14 0.2× 7 0.1× 5 0.1× 60 1.6× 23 149
Abdullah Tunçez Türkiye 8 72 0.8× 26 0.4× 2 0.0× 2 0.1× 49 1.3× 31 165
Ilham Benzidia France 5 34 0.4× 9 0.1× 9 0.2× 8 0.2× 18 0.5× 12 89
Myftar Barbullushi Albania 6 29 0.3× 7 0.1× 15 0.3× 1 0.0× 23 0.6× 43 174

Countries citing papers authored by Stuart Keller

Since Specialization
Citations

This map shows the geographic impact of Stuart Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Keller more than expected).

Fields of papers citing papers by Stuart Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Keller. The network helps show where Stuart Keller may publish in the future.

Co-authorship network of co-authors of Stuart Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Keller. A scholar is included among the top collaborators of Stuart Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Keller. Stuart Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Ramanan, Athimalaipet V, Catherine Guly, Gabriele Simonini, et al.. (2025). Effectiveness and Safety of Baricitinib for Juvenile Idiopathic Arthritis–Associated Uveitis or Chronic Anterior Antinuclear Antibody–Positive Uveitis. Arthritis Care & Research.
3.
Krishnan, Venkatesh, Stuart Keller, Christine Chew, et al.. (2025). Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial. The Lancet Rheumatology. 7(11). e799–e807. 1 indexed citations
4.
Ernest, C. Steven, et al.. (2024). A population pharmacokinetic model using allometric scaling for baricitinib in patients with juvenile idiopathic arthritis. CPT Pharmacometrics & Systems Pharmacology. 13(6). 970–981. 3 indexed citations
5.
6.
7.
Paller, Amy S., Marieke M.B. Seyger, Jerry Bagel, et al.. (2020). Efficacy and safety of ixekizumab in a phase III , randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis ( IXORA ‐ PEDS ). British Journal of Dermatology. 183(2). 231–241. 69 indexed citations
8.
Effron, Mark B., Kavita Nair, Stuart Keller, et al.. (2017). One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database. American Journal of Cardiovascular Drugs. 18(2). 129–141. 7 indexed citations
9.
Wayangankar, Siddharth A., Usman Baber, Kanhaiya L. Poddar, et al.. (2016). PREDICTORS OF 1 YEAR NET ADVERSE CARDIOVASCULAR EVENTS (NACE) AMONG ACS PATIENTS UNDERGOING PCI WITH CLOPIDOGREL OR PRASUGREL: ANALYSIS FROM THE PROMETHEUS REGISTRY. Journal of the American College of Cardiology. 67(13). 562–562. 1 indexed citations
10.
Chandrasekhar, Jaya, Usman Baber, Samantha Sartori, et al.. (2016). Sex‐related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study. Catheterization and Cardiovascular Interventions. 89(4). 629–637. 54 indexed citations
11.
Chandrasekhar, Jaya, Usman Baber, Samantha Sartori, et al.. (2015). TCT-221 Impact of prasugrel versus clopidogrel in smokers and non-smokers undergoing PCI for ACS: Results from the PROMETHEUS Study. Journal of the American College of Cardiology. 66(15). B85–B86. 1 indexed citations
12.
Simeone, Jason C., Elizabeth Marrett, Feride Frech‐Tamas, et al.. (2015). One-Year Post-Discharge Resource Utilization and Treatment Patterns of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention and Treated with Ticagrelor or Prasugrel. American Journal of Cardiovascular Drugs. 15(5). 337–350. 18 indexed citations
13.
Schweitzer, Paul & Stuart Keller. (2002). A history of atrial fibrillation.. PubMed. 48 Suppl 1. 24–6. 3 indexed citations
14.
Keller, Stuart, et al.. (2001). Neuropsychiatric manifestations of cardiovascular drug therapy.. PubMed. 1(4). 241–54. 2 indexed citations
15.
Schweitzer, Paul & Stuart Keller. (2001). The role of the initial 12-lead ECG in risk stratification of patients with acute coronary syndrome.. PubMed. 102(9). 406–11. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacek Musiał Breakdown of academic impact, for papers by Kathrin Danninger Breakdown of academic impact, for papers by Karolis Ažukaitis Breakdown of academic impact, for papers by Bassam Mahboub Breakdown of academic impact, for papers by Nicole Michon Breakdown of academic impact, for papers by Hannah Fleming Breakdown of academic impact, for papers by François-Xavier Lapébie Breakdown of academic impact, for papers by Abdullah Tunçez Breakdown of academic impact, for papers by Ilham Benzidia Breakdown of academic impact, for papers by Myftar Barbullushi
Rankless by CCL
2026